Cue Biopharma to Present at Two Upcoming Investor Healthcare Conferences in June 2024
Cue Biopharma, a clinical-stage biopharmaceutical company, will participate in two significant investor healthcare conferences this June 2024. The company, listed on Nasdaq with the ticker CUE, focuses on developing therapeutic biologics targeting disease-specific T cells.
On June 6, Cue Biopharma will present at the Jefferies Global Healthcare Conference in New York, discussing its progress in oncology and autoimmune platforms. The presentation by Anish Suri, Ph.D., President and Chief Scientific Officer, will be available via webcast.
On June 24, the company will participate in the Oppenheimer Novel Targets and Immunology Summit, also in New York. Dr. Suri will join a panel to discuss repurposing cancer targets for immunology. These events will provide updates on clinical and preclinical advancements and strategic approaches.
- Cue Biopharma is gaining exposure by participating in prominent investor healthcare conferences.
- Presentation at Jefferies Global Healthcare Conference highlights progress in oncology and autoimmune platforms.
- Participation in Oppenheimer Novel Targets and Immunology Summit showcases expertise in repurposing cancer targets for immunology.
- Webcasts of the presentations will be available, increasing transparency and investor engagement.
- No new clinical data or significant milestones announced in the press release.
- Potential for increased scrutiny and pressure from investors following the presentations.
- Events may not lead to immediate financial gains or stock price increases.
BOSTON, June 03, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells, today announced that it will participate in two investor conferences this June, the Jefferies Global Healthcare Conference, to be held in New York, NY, June 4-6 and the Oppenheimer Novel Targets and Immunology Summit, to be held in New York, NY on June 24.
Cue Biopharma will discuss current clinical and preclinical progress as well as strategy in the advancement of its oncology and autoimmune platforms and biologics.
Presentation Details
Jefferies Global Healthcare Conference
Date and Time: Thursday, June 6 from 2:00 – 2:25 p.m. EDT
Webcast Link: https://wsw.com/webcast/jeff302/cue/1681744
Presenter: Anish Suri, Ph.D., president and chief scientific officer, Cue Biopharma
Oppenheimer Novel Targets and Immunology Summit
Panel Presentation Date and Time: Monday, June 24 from 11:00 – 11:40 a.m. EDT
Panel: Repurposing Cancer Targets for Immunology
Presenter: Anish Suri, Ph.D., president and chief scientific officer, Cue Biopharma
A live and archived webcast of the presentation for the Jefferies Global Healthcare Conference will be available on the Events page in the Investors and Media section of the Company’s website at www.cuebiopharma.com. The webcast will be archived for 30 days.
About Cue Biopharma
Cue Biopharma, a clinical-stage biopharmaceutical company, is developing a novel class of injectable biologics to selectively engage and modulate disease-specific T cells directly within the patient’s body. The company’s proprietary platform, Immuno-STAT™ (Selective Targeting and Alteration of T cells) and biologics are designed to harness the curative potential of the body’s intrinsic immune system through the selective modulation of disease-specific T cells without the adverse effects of broad systemic immune modulation.
Headquartered in Boston, Massachusetts, we are led by an experienced management team and independent Board of Directors with deep expertise in immunology and immuno-oncology as well as the design and clinical development of protein biologics.
For more information please visit www.cuebiopharma.com and follow us on X and LinkedIn.
Investor Contact
Marie Campinell
Senior Director, Corporate Communications
Cue Biopharma, Inc.
mcampinell@cuebio.com
Media Contact
Jonathan Pappas
LifeSci Communications
jpappas@lifescicomms.com
![](https://ml.globenewswire.com/media/YzYwZGE5ZmItM2U5ZC00YmM0LTlkY2QtNmQ0ZGI0ZDIzNjI1LTExMDQyNjM=/tiny/Cue-Biopharma-Inc-.png)
FAQ
What conferences is Cue Biopharma attending in June 2024?
When is Cue Biopharma presenting at the Jefferies Global Healthcare Conference?
Where can I watch the webcast of Cue Biopharma's presentation at the Jefferies Global Healthcare Conference?
What will Cue Biopharma discuss at the Jefferies Global Healthcare Conference?
When is the Oppenheimer Novel Targets and Immunology Summit panel featuring Cue Biopharma?